ARTICLE | Clinical News
Cytogen regulatory update
March 20, 1995 8:00 AM UTC
Cytogen Corp. (CYTO) The FDA accepted for filing the Princeton, N.J., company's PLA and ELA for ProstaScint, a monoclonal antibody-based imaging agent that detects the presence and extent of prostate...